Home › Stock analysis › MIST
Milestone Pharmaceuticals (MIST) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
What changed since yesterday
- Closed at $0.71, -11.03% vs the prior close of $0.80.
- Volume 974.36K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
MIST slides 11.0% to $0.71, a 52-week low. Closed at $0.71, -11.03% vs the prior close of $0.80. Day range $0.70–$0.80, opened at $0.80.
Last close$0.71-11.03%
Day range0.70–0.80
Open0.80
Volume974.36K
52-week range0.70–3.06
Avg volume (20d)1.14M
MIST daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — MIST slides 11.0% to $0.71, a 52-week low
- Closed at $0.71, -11.03% vs the prior close of $0.80. Day range $0.70–$0.80, opened at $0.80.
- Volume was 974.36K shares, 0.7x its 50-day average of 1.49M.
- Price is -27.6% vs its 50-day average ($0.98) and -50.9% vs its 200-day average ($1.44).
- 52-week range $0.70–$3.06; today's close sits at 0% of that range, 76.9% below the 52-week high.
Oct 15, 2026 — MIST rises 0.9% to $0.80
- Closed at $0.80, +0.89% vs the prior close of $0.79. Day range $0.75–$0.80, opened at $0.79.
- Volume was 1.03M shares, 0.7x its 50-day average of 1.48M.
- Price is -19.4% vs its 50-day average ($0.99) and -45.1% vs its 200-day average ($1.45).
- 52-week range $0.71–$3.06; today's close sits at 4% of that range, 74.0% below the 52-week high.
Oct 14, 2026 — MIST rises 2.9% to $0.79
- Closed at $0.79, +2.87% vs the prior close of $0.77. Day range $0.75–$0.80, opened at $0.76.
- Volume was 807.10K shares, 0.5x its 50-day average of 1.49M — lighter than usual.
- Price is -20.7% vs its 50-day average ($0.99) and -45.8% vs its 200-day average ($1.45).
- 52-week range $0.71–$3.06; today's close sits at 3% of that range, 74.2% below the 52-week high.
Oct 13, 2026 — MIST slides 5.0% to $0.77
- Closed at $0.77, -4.96% vs the prior close of $0.81. Day range $0.75–$0.81, opened at $0.79.
- Volume was 1.20M shares, 0.8x its 50-day average of 1.49M.
- Price is -23.5% vs its 50-day average ($1.00) and -47.5% vs its 200-day average ($1.46).
- 52-week range $0.71–$3.06; today's close sits at 3% of that range, 75.0% below the 52-week high.
Oct 12, 2026 — MIST jumps 5.4% to $0.81
- Closed at $0.81, +5.36% vs the prior close of $0.76. Day range $0.74–$0.81, opened at $0.78.
- Volume was 1.17M shares, 0.8x its 50-day average of 1.48M.
- Price is -20.1% vs its 50-day average ($1.01) and -45.0% vs its 200-day average ($1.47).
- 52-week range $0.71–$3.06; today's close sits at 4% of that range, 73.7% below the 52-week high.
Oct 9, 2026 — MIST jumps 7.4% to $0.76
- Closed at $0.76, +7.44% vs the prior close of $0.71. Day range $0.71–$0.77, opened at $0.72.
- Volume was 1.23M shares, 0.8x its 50-day average of 1.49M.
- Price is -24.6% vs its 50-day average ($1.01) and -48.0% vs its 200-day average ($1.47).
- 52-week range $0.71–$3.06; today's close sits at 2% of that range, 75.0% below the 52-week high.
Oct 8, 2026 — MIST slides 5.9% to $0.71, a 52-week low, 6 down days in a row
- Closed at $0.71, -5.94% vs the prior close of $0.76. Day range $0.71–$0.77, opened at $0.77.
- Volume was 1.39M shares, 0.9x its 50-day average of 1.51M.
- Price is -30.3% vs its 50-day average ($1.02) and -51.8% vs its 200-day average ($1.48).
- 52-week range $0.71–$3.06; today's close sits at 0% of that range, 76.7% below the 52-week high.
- That makes 6 straight losses.
Oct 7, 2026 — MIST dips 0.9% to $0.76, a 52-week low, 5 down days in a row
- Closed at $0.76, -0.92% vs the prior close of $0.76. Day range $0.73–$0.77, opened at $0.76.
- Volume was 887.00K shares, 0.6x its 50-day average of 1.55M — lighter than usual.
- Price is -26.4% vs its 50-day average ($1.03) and -49.1% vs its 200-day average ($1.49).
- 52-week range $0.73–$3.06; today's close sits at 1% of that range, 75.3% below the 52-week high.
- That makes 5 straight losses.
Oct 6, 2026 — MIST dips 1.9% to $0.76, a 52-week low, 4 down days in a row
- Closed at $0.76, -1.93% vs the prior close of $0.78. Day range $0.76–$0.81, opened at $0.80.
- Volume was 1.39M shares, 0.9x its 50-day average of 1.54M.
- Price is -26.2% vs its 50-day average ($1.03) and -48.8% vs its 200-day average ($1.49).
- 52-week range $0.75–$3.06; today's close sits at 1% of that range, 75.0% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — MIST slides 3.8% to $0.78, a 52-week low, 3 down days in a row
- Closed at $0.78, -3.83% vs the prior close of $0.81. Day range $0.77–$0.82, opened at $0.82.
- Volume was 1.08M shares, 0.7x its 50-day average of 1.54M.
- Price is -25.3% vs its 50-day average ($1.04) and -48.0% vs its 200-day average ($1.50).
- 52-week range $0.75–$3.06; today's close sits at 1% of that range, 74.5% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — MIST dips 0.7% to $0.81
- Closed at $0.81, -0.74% vs the prior close of $0.82. Day range $0.79–$0.83, opened at $0.82.
- Volume was 768.40K shares, 0.5x its 50-day average of 1.54M — lighter than usual.
- Price is -22.8% vs its 50-day average ($1.05) and -46.2% vs its 200-day average ($1.51).
- 52-week range $0.75–$3.06; today's close sits at 3% of that range, 73.5% below the 52-week high.
MIST latest news & SEC filings
Every SEC filing by or about MIST in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $559.00K (prior year $0)
- Net income: -$28.61M (prior year -$12.97M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.21 (prior year -$0.20) (loss widened vs Jun 30, 2025)
Aug 7, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade MIST
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 20, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 11, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.85% (largest 11.0%). That is a volatile stock.
- Liquidity: about 1.14M shares (≈$805.31K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.71 vs a range of $0.70–$3.06 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Joseph Oliveto sold 36,500 shares on Apr 16, 2026.
- Latest filings: 8-K Sep 3, 2026; 8-K Aug 12, 2026; 10-Q Aug 12, 2026.
- Share count: 124.50M shares outstanding (Aug 12, 2026), +46.5% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
MIST market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.80 | 0.80 | 0.70 | 0.71 | 974.36K |
| Oct 15, 2026 | 0.79 | 0.80 | 0.75 | 0.80 | 1.03M |
| Oct 14, 2026 | 0.76 | 0.80 | 0.75 | 0.79 | 807.10K |
| Oct 13, 2026 | 0.79 | 0.81 | 0.75 | 0.77 | 1.20M |
| Oct 12, 2026 | 0.78 | 0.81 | 0.74 | 0.81 | 1.17M |
| Oct 9, 2026 | 0.72 | 0.77 | 0.71 | 0.76 | 1.23M |
| Oct 8, 2026 | 0.77 | 0.77 | 0.71 | 0.71 | 1.39M |
| Oct 7, 2026 | 0.76 | 0.77 | 0.73 | 0.76 | 887.00K |
| Oct 6, 2026 | 0.80 | 0.81 | 0.76 | 0.76 | 1.39M |
| Oct 5, 2026 | 0.82 | 0.82 | 0.77 | 0.78 | 1.08M |
| Oct 2, 2026 | 0.82 | 0.83 | 0.79 | 0.81 | 768.40K |
| Oct 1, 2026 | 0.88 | 0.90 | 0.81 | 0.82 | 719.50K |
| Sep 30, 2026 | 0.84 | 0.90 | 0.82 | 0.87 | 1.27M |
| Sep 29, 2026 | 0.78 | 0.83 | 0.78 | 0.82 | 931.40K |
| Sep 28, 2026 | 0.78 | 0.82 | 0.78 | 0.80 | 418.40K |
| Sep 25, 2026 | 0.80 | 0.81 | 0.75 | 0.79 | 1.26M |
| Sep 24, 2026 | 0.88 | 0.88 | 0.78 | 0.80 | 2.33M |
| Sep 23, 2026 | 0.93 | 0.93 | 0.85 | 0.86 | 1.53M |
| Sep 22, 2026 | 0.92 | 0.93 | 0.89 | 0.92 | 1.72M |
| Sep 21, 2026 | 0.93 | 0.93 | 0.90 | 0.92 | 674.00K |
About Milestone Pharmaceuticals
Milestone Pharmaceuticals (MIST) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in MONTREAL, Quebec, Canada. State of incorporation: Quebec, Canada. Fiscal year ends December 31. SEC CIK 1408443.
MIST board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Stuart Duty | Director | Jun 12, 2026 |
| Seth H. Z. Fischer | Director | Jun 12, 2026 |
| Lisa M. Giles | Director | Jun 12, 2026 |
| Joseph Oliveto | President and CEO | Apr 20, 2026 |
| Joseph C Papa | Director | Jun 12, 2026 |
| Andrew Saik | Director | Jun 12, 2026 |
| Michael John Tomsicek | Director | Jun 12, 2026 |
| Robert James Wills | Director | Jun 12, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| David Bharucha | Chief Medical Officer | Feb 5, 2026 |
| Amit Hasija | CFO & EVP of Corp. Development | Feb 5, 2026 |
| Lorenz Muller | Chief Commercial Officer | Feb 5, 2026 |
| Jeffrey Edward Nelson | Chief Operating Officer | Feb 5, 2026 |
| Joseph Oliveto | President and CEO | Apr 20, 2026 |
| David I. Sandoval | GC & Chief Compliance Officer | Mar 23, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Apr 16, 2026 | Joseph Oliveto | Sale | 36,500 | $2.26 |
| Apr 16, 2026 | Joseph Oliveto | Sale | 36,500 | $2.26 |
| Apr 16, 2026 | Joseph Oliveto | Sale | 36,500 | $2.26 |
| Apr 16, 2026 | Joseph Oliveto | Sale | 36,500 | $2.26 |
| Jan 26, 2026 | David Bharucha | Sale | 12,245 | $1.93 |
| Jan 26, 2026 | David Bharucha | Sale | 12,245 | $1.93 |
| Jan 26, 2026 | David Bharucha | Sale | 12,245 | $1.93 |
| Jan 26, 2026 | David Bharucha | Sale | 12,245 | $1.93 |
| Jan 26, 2026 | Lorenz Muller | Sale | 11,180 | $1.93 |
| Jan 26, 2026 | Lorenz Muller | Sale | 11,180 | $1.93 |
| Jan 26, 2026 | Lorenz Muller | Sale | 11,180 | $1.93 |
| Jan 26, 2026 | Lorenz Muller | Sale | 11,180 | $1.93 |
| Jan 26, 2026 | Amit Hasija | Sale | 12,245 | $1.93 |
| Jan 26, 2026 | Amit Hasija | Sale | 12,245 | $1.93 |
| Jan 26, 2026 | Amit Hasija | Sale | 12,245 | $1.93 |
MIST financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-63.06M | -0.75 | $-49.04M |
| Dec 31, 2024 | — | $-41.52M | -0.67 | $-28.85M |
| Dec 31, 2023 | — | $-59.69M | -1.39 | $-46.42M |
| Dec 31, 2022 | — | $-58.39M | -1.38 | $-52.47M |
| Dec 31, 2021 | — | $-42.85M | -1.02 | $-33.22M |
Latest balance sheet: total assets $181.62M, total liabilities $163.41M, cash $169.73M (as of Jun 30, 2026).
MIST earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | $1.12 |
| May 13, 2026 | 8-K Item 2.02 (results) | $1.72 |
| Mar 20, 2026 | 8-K Item 2.02 (results) | $1.36 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $1.93 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $1.66 |
| May 14, 2025 | 8-K Item 2.02 (results) | $1.17 |
| Mar 13, 2025 | 8-K Item 2.02 (results) | $2.03 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $1.87 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 13, 2024 | 8-K Item 2.02 (results) | — |
| Mar 21, 2024 | 8-K Item 2.02 (results) | — |
| Nov 13, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on MIST
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.